Cargando…

Response to Tomao, Panici, and Tomao

Detalles Bibliográficos
Autores principales:	Vos, Janet R, Ligtenberg, Marjolijn J L, Hoogerbrugge, Nicoline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156924/ https://www.ncbi.nlm.nih.gov/pubmed/31287552 http://dx.doi.org/10.1093/jnci/djz140

Ejemplares similares

Reply to F. Tomao et al
por: Ribi, Karin, et al.
Publicado: (2016)

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021)

Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome
por: Vos, Janet R., et al.
Publicado: (2020)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
por: Vos, Janet R., et al.
Publicado: (2018)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
por: Sie, Aisha S, et al.
Publicado: (2012)

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling
por: Sie, Aisha S., et al.
Publicado: (2015)

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
por: Eissing, Marc, et al.
Publicado: (2018)

Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma
por: Boesaard, Ewout P, et al.
Publicado: (2014)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic
por: Overbeek, Lucia I. H., et al.
Publicado: (2008)

A review on age‐related cancer risks in PTEN hamartoma tumor syndrome
por: Hendricks, Linda A.J., et al.
Publicado: (2020)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
por: Dekker, Nicky, et al.
Publicado: (2010)

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome
por: Hoxhaj, Alma, et al.
Publicado: (2022)

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
por: Witjes, Vera M., et al.
Publicado: (2022)

Subcutaneous glucose measurements and glucose regulation (?)
por: Ligtenberg, Jack J., et al.
Publicado: (2010)

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect
por: Vogelaar, Ingrid P., et al.
Publicado: (2015)

NTHL1 defines novel cancer syndrome
por: Kuiper, Roland P., et al.
Publicado: (2015)

“Patient Journeys”: improving care by patient involvement
por: Bolz-Johnson, Matt, et al.
Publicado: (2019)

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
por: van Veen, E. J. W., et al.
Publicado: (2007)

Comment on Mackenzie and Woodhouse: C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction
por: Droogh, Joep M., et al.
Publicado: (2007)

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
por: Tischkowitz, Marc, et al.
Publicado: (2020)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
por: de Voer, Richarda M., et al.
Publicado: (2015)

Attributes and Features of Context Relevant to Knowledge Translation in Health Settings: A Response to Recent Commentaries
por: Squires, Janet E., et al.
Publicado: (2023)

Investigating Resilience in Healthcare: Easier Said Than Done? A Response to the Recent Commentaries
por: Smaggus, Andrew, et al.
Publicado: (2022)

A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients
por: Zhang, Junxiao, et al.
Publicado: (2017)

Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
por: Visser, Annemiek, et al.
Publicado: (2011)

Authors’ response
por: Ramzi, N. H., et al.
Publicado: (2015)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

Response to Rubanovich et al.
por: Hayeems, R. Z., et al.
Publicado: (2019)

Authors’ response
por: Khandare, A.L., et al.
Publicado: (2015)

Authors’ response
por: Oberoi, J.K., et al.
Publicado: (2014)

Response to Caro and Winter
por: Harte, Steven E., et al.
Publicado: (2019)

Response
por: Lamb, Carla R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mc5u40hmmpkmnq2frtnm03e3b8